FDA weighs myocarditis risk in review of Pfizer COVID vaccine for kids
The analysis was posted late Friday ahead of a meeting of the agency's vaccine advisers to discuss the benefits and risks of vaccinating younger children.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
The analysis was posted late Friday ahead of a meeting of the agency's vaccine advisers to discuss the benefits and risks of vaccinating younger children.
A panel of the FDA's vaccine advisers will be discussing the data on Tuesday.
Up to 99 million Americans are now eligible for an additional dose.
The CDC must also weigh in before additional doses can be administered nationwide.
Powell, who was fully vaccinated, had been treated for multiple myeloma before dying from COVID-19 complications.
New CDC data suggests the single-shot vaccine has the highest rate of breakthrough infections.
The committee is also scheduled to vote on Johnson & Johnson's request tomorrow.
The uptick comes as the Biden administration touts new vaccination requirements.
Rural adults are among the most likely to say they would "definitely not" get vaccinated, according to a recent poll.
More than 22,000 pregnant Americans have been hospitalized with COVID-19, and data suggests 97% of them were unvaccinated.
New study analyzed early reports from thousands of Americans who received an additional dose already.
The CDC director defended the decision, after differing on one key point with a panel of vaccine advisers
Third doses of the Pfizer vaccine could be available to seniors and other at-risk groups this week.
Third doses could roll out this week, pending a review by CDC advisers
When can kids get vaccinated? Are Delta variant symptoms worse?